Core Viewpoint - Dynavax Technologies Corporation is urging stockholders to vote "FOR" its four director nominees in response to a proxy contest initiated by Deep Track Capital, emphasizing the company's strong financial performance and strategic direction [1][2][3] Financial Performance - Dynavax has achieved total stockholder returns of 267% over the past five years, significantly outperforming the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index [3][9] - The company reported a substantial increase in HEPLISAV-B® net product revenue, growing from $36 million in 2020 to a record $268 million in 2024, representing a 65% compound annual growth rate [9] - Anticipated net product revenue for HEPLISAV-B® in 2025 is projected to be between $305 million and $325 million, with expectations for the U.S. hepatitis B adult vaccine market to peak at over $900 million by 2030 [9] Strategic Direction - Dynavax is executing a disciplined capital allocation strategy, including a $200 million share repurchase program, of which $128.8 million has already been executed as of the end of Q1 2025 [8][9] - The company has refocused its portfolio on vaccines, successfully launching HEPLISAV-B® and advancing its differentiated vaccine pipeline [7][9] - Dynavax's board has been programmatically refreshed, with new directors possessing extensive experience in biotechnology and vaccine development [11][12] Governance and Board Composition - The board nominees proposed by Dynavax are described as highly qualified, with significant experience in the biotechnology sector, contrasting with the unqualified candidates put forth by Deep Track [3][15][18] - The board has implemented corporate governance enhancements, including a proposal to declassify the board, which aims to improve accountability and responsiveness to stockholders [12][19] Proxy Contest Context - Deep Track Capital is attempting to gain control of the Dynavax board to implement a short-term strategy that the company believes would be detrimental to long-term value creation [5][14][17] - Dynavax has made multiple attempts to reach a settlement with Deep Track to avoid a costly proxy contest, but these efforts have been met with resistance [16][17]

Financial Data and Key Metrics Changes - Revenue less ancillary services grew by 17.4% year over year to $112.8 million in Q4 2024, but was lower than guidance by approximately $8 million due to macro factors, particularly in Canada and foreign exchange impacts [33][34] - Adjusted EBITDA increased to $16.7 million for the quarter, compared to $7.7 million in Q4 2023, with an adjusted EBITDA margin up nearly 700 basis points year over year [36][37] - GAAP net income reflected a loss of $15.9 million, primarily due to a one-time non-cash foreign exchange loss of $14 million on intercompany loans [38] Business Line Data and Key Metrics Changes - The travel vertical grew organically by more than 50% in 2024, becoming the second largest vertical, contributing 13% of total revenue, up from 7% two years ago [23][24] - The education vertical in EMEA and the UK saw over 50% year-over-year revenue growth, despite headwinds from visa policy changes [16][20] - The healthcare vertical secured a landmark eight-figure relationship with a major hospital system, indicating strong market receptiveness [27] Market Data and Key Metrics Changes - Canadian higher education revenue was down over 50% year over year, resulting in a significant headwind to overall growth [34][60] - The U.S. market experienced slower growth due to shifting visa trends, with F-1 visa issuance down approximately 10% [92] - The company anticipates revenue in Canada and Australia to be down over 30% year over year due to recent policy changes [44][68] Company Strategy and Development Direction - The company announced the acquisition of Certify, which is expected to enhance its presence in the travel vertical and provide access to new subsegments of the global travel industry [10][26] - A comprehensive operational and portfolio review is underway to optimize investments across geographies, products, and verticals [12][65] - The company is focusing on product innovation, particularly in vertical-specific software for complex payments, and aims to enhance its go-to-market strategy [29][30] Management's Comments on Operating Environment and Future Outlook - Management acknowledged significant macro headwinds, particularly in the education sector due to visa policy changes, but expressed confidence in the long-term demand for international education [9][20] - The company is strategically investing in new products and payment network capabilities to offset macro challenges and diversify revenue [9][41] - Management expects continued growth in EMEA education, travel, and B2B segments, while projecting a cautious outlook for the U.S. market [46][75] Other Important Information - The restructuring plan announced will affect approximately 10% of the workforce, with expected charges between $7 million to $9 million [37][47] - The company has repurchased 2.3 million shares for approximately $44 million as part of its buyback program [39] - The acquisition of Certify is expected to contribute approximately $35 million to $40 million in revenue in 2025 [43] Q&A Session Summary Question: Can you talk about the NRR? - Management indicated that NRR was 114% in 2024, with expectations for a further decline in 2025 due to visa dynamics in Canada and Australia [50][51] Question: Why is the portfolio review happening now? - Management stated that ongoing policy restrictions prompted a review to control internal factors and optimize investments [54][56] Question: What is the impact of the SDS policy in Canada? - Management explained that the SDS policy change has led to significant demand destruction, affecting overall student enrollments and payments [60][61] Question: How is the education market performing outside Canada and Australia? - Management noted strong growth in the UK and EMEA markets, while the APAC region is also showing good opportunities [75] Question: What are the expectations for gross profit margins in 2025? - Management anticipates a decline in gross profit margins due to a mix of faster-growing verticals, estimating a drop of 100 to 200 basis points [80]